CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mispro Biotech Services (“Mispro”) today announced expansion of its services into the Massachusetts biotechnology supercluster with its on-site vivarium services solution, Mispro Insource. Mispro Insource is a comprehensive vivarium services solution that enables research organizations to focus on science, while Mispro handles all other aspects of vivarium operations in support of preclinical drug and product development.
Mispro’s comprehensive insource solution includes:
- On-site vivarium management & operations, including staffing, animal husbandry & veterinary services and facility maintenance
- Compliance & regulatory oversight, including AAALAC-accreditation, Institutional Animal Care and Use Committee (IACUC) and OLAW/PHS Assurance
- Training & certification for staff and principal investigators
“Running an in vivo research program is complex, time-consuming and expensive,” said Dr. Keith Astrofsky, DVM, Director of Operations at Mispro. “With our insource offering, Mispro provides the people, infrastructure, and know-how to run vivarium research facilities in a safe, humane, and compliant manner, giving back considerable time and resources to client companies so they can focus instead on their drug development programs.”
Mispro offers extensive experience in vivarium operations and services, having grown a network of off-site vivarium facilities in key North American biotech hubs since its founding in 2003, including a facility in Kendall Square that opened in 2014. Mispro supports multiple clients in its facilities, giving them access to research and animal housing space while also providing all animal care and compliance services.
“Expansion into insourcing in the Cambridge-Boston market is a natural progression for Mispro,” adds Astrofsky. “We’ve seen first-hand the benefits to our clients’ research programs that our services and managed environments have provided, and we’ve had several clients grow into their own vivarium facilities and ask us to run those research facilities. That, along with our success providing insourcing in other markets, is a good indicator for us that what we’re offering is of real value.”
Synlogic Therapeutics, pioneers in the development of a novel class of living Synthetic Biotic™ medicines, is one of those companies. “Having Mispro handle the activities surrounding husbandry, staffing, preparing the facility for future accreditation, and setting up the IACUC has meant that Synlogic staff are able to fully focus on research,” said Kip West, Ph.D., Synlogic’s Director of Immunomodulation.
About Mispro Biotech Services
Since 2003, Mispro Biotech
Services has offered biopharmaceutical and life science companies access
to state-of-the-art vivarium research space plus comprehensive
laboratory animal science services supporting preclinical drug
development. With a network of vivarium facilities conveniently located
in key biotech and life science clusters in the U.S. and Canada
including Cambridge, Mass., Farmingdale, N.Y., New York City, Research
Triangle Park, N.C. and Montreal, Mispro offers an affordable and
scalable option for research organizations who do not have access to a
vivarium but choose to conduct and control their own studies. In
2019-2020, Mispro is planning to expand in the U.S. as well as Europe.
